EUVIMEDEUVIMED entdecken
Crossref

Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be)

Mathieu Daoud, Farida Benhadou, Mariano Suppa, Anne-Sophie Sarkis, Stéphanie Heudens, Lila Desmarest, Hassane Njimi, Mathilde Daxhelet, Laura Nobile, Jalila Karama, Jonathan M White, Gregor B E Jemec und 1 weitere

Archives of Dermatological Research · 07.01.2025 · 317 (1)

DOI: 10.1007/s00403-024-03675-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Dermatological Research, online erschienen am 07.01.2025. Verfasst von Mathieu Daoud und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. daoud.mathieu@gmail.com. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Adalimumab, Registries, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hidradenitis SuppurativaAdalimumabRegistriesSeverity of Illness IndexHumansMaleFemaleAdultBelgiumRetrospective StudiesTreatment OutcomeMiddle AgedYoung AdultPhenotypeAnti-Inflammatory Agents

Stichwörter der Autor:innen

AdalimumabHidradenitis suppurativaOutcomePersonalised medicinePredictorScoring

Substanzen

AdalimumabAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. daoud.mathieu@gmail.com.
  • Department of Dermatology, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Department of Dermatology, Zealand University Hospital, Roskilde, Denmark.
  • Health Sciences Faculty, University of Copenhagen, Copenhagen, Denmark.

Zitieren

APA

Daoud, M., Benhadou, F., Suppa, M., Sarkis, A. S., Heudens, S., Desmarest, L., Njimi, H., Daxhelet, M., Nobile, L., Karama, J., White, J. M., Jemec, G. B. E., & Del Marmol, V. (2025). Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be). Archives of Dermatological Research, 317(1). https://doi.org/10.1007/s00403-024-03675-w

Vancouver

Daoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, et al. Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be). Archives of Dermatological Research. 2025;317(1). doi:10.1007/s00403-024-03675-w

BibTeX
@article{Daoud2025,
  author = {Daoud, Mathieu and Benhadou, Farida and Suppa, Mariano and Sarkis, Anne-Sophie and Heudens, Stéphanie and Desmarest, Lila and Njimi, Hassane and Daxhelet, Mathilde and Nobile, Laura and Karama, Jalila and White, Jonathan M and Jemec, Gregor B E and Del Marmol, Véronique},
  title = {Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be)},
  journal = {Archives of Dermatological Research},
  year = {2025},
  volume = {317},
  number = {1},
  doi = {10.1007/s00403-024-03675-w}
}
Kostenlos starten →